Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Breakthru Medicine emerges from stealth with the close of a $60M Series A financing round following a prior undisclosed seed round. Breakthru was founded by biotech industry veterans Steve Potts, PhD, ...

Over ten years, Sanyou Bio has built a 10-trillion--scale Intelligent Super-Trillion Antibody Library, which serves as the cornerstone of its competitiveness. Today, most domestic molecular libraries ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

The biotech industry has certainly hit the ground running in 2026. In its first edition of the year, the biotech bi-weekly highlights new products that can visualize multimodal biological data at ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in ...

Americans spent more than $700 billion on prescription medicines last year. However, many of them remain worried about the safety of their medications.